MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$148.34
+2.53%Forward multiples
Based on analyst estimates
- P/E forward
- 17.46x
- P/E 2026E
- 52.89x
- P/E 2027E
- 16.01x
- P/E 2028E
- 14.55x
- P/S forward
- 5.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 151.36x
- PEG TTM
- 0.19x
- Price / book
- —
- Price / sales
- 5.44x
- Price / cash flow
- 22.22x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- $366.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026